UniProt ID | SEN34_HUMAN | |
---|---|---|
UniProt AC | Q9BSV6 | |
Protein Name | tRNA-splicing endonuclease subunit Sen34 | |
Gene Name | TSEN34 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 310 | |
Subcellular Localization | Nucleus . Nucleus, nucleolus . May be transiently localized in the nucleolus. | |
Protein Description | Constitutes one of the two catalytic subunit of the tRNA-splicing endonuclease complex, a complex responsible for identification and cleavage of the splice sites in pre-tRNA. It cleaves pre-tRNA at the 5'- and 3'-splice sites to release the intron. The products are an intron and two tRNA half-molecules bearing 2',3'-cyclic phosphate and 5'-OH termini. There are no conserved sequences at the splice sites, but the intron is invariably located at the same site in the gene, placing the splice sites an invariant distance from the constant structural features of the tRNA body. It probably carries the active site for 3'-splice site cleavage. The tRNA splicing endonuclease is also involved in mRNA processing via its association with pre-mRNA 3'-end processing factors, establishing a link between pre-tRNA splicing and pre-mRNA 3'-end formation, suggesting that the endonuclease subunits function in multiple RNA-processing events.. | |
Protein Sequence | MLVVEVANGRSLVWGAEAVQALRERLGVGGRTVGALPRGPRQNSRLGLPLLLMPEEARLLAEIGAVTLVSAPRPDSRHHSLALTSFKRQQEESFQEQSALAAEARETRRQELLEKITEGQAAKKQKLEQASGASSSQEAGSSQAAKEDETSDGQASGEQEEAGPSSSQAGPSNGVAPLPRSALLVQLATARPRPVKARPLDWRVQSKDWPHAGRPAHELRYSIYRDLWERGFFLSAAGKFGGDFLVYPGDPLRFHAHYIAQCWAPEDTIPLQDLVAAGRLGTSVRKTLLLCSPQPDGKVVYTSLQWASLQ | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
|
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
38 | Methylation | RTVGALPRGPRQNSR CCCCCCCCCCCCCCC | 69.47 | 54560365 | |
67 | Phosphorylation | LAEIGAVTLVSAPRP HHHHCCEEEEECCCC | 22.40 | 28348404 | |
70 | Phosphorylation | IGAVTLVSAPRPDSR HCCEEEEECCCCCCC | 35.35 | 28348404 | |
76 | Phosphorylation | VSAPRPDSRHHSLAL EECCCCCCCCCHHHH | 35.88 | 28348404 | |
80 | Phosphorylation | RPDSRHHSLALTSFK CCCCCCCHHHHHHHH | 14.82 | 20873877 | |
84 | Phosphorylation | RHHSLALTSFKRQQE CCCHHHHHHHHHHHH | 26.89 | 26434776 | |
85 | Phosphorylation | HHSLALTSFKRQQEE CCHHHHHHHHHHHHH | 29.62 | 26434776 | |
87 | Acetylation | SLALTSFKRQQEESF HHHHHHHHHHHHHHH | 49.41 | 24469671 | |
87 | Methylation | SLALTSFKRQQEESF HHHHHHHHHHHHHHH | 49.41 | 24469671 | |
87 | Sumoylation | SLALTSFKRQQEESF HHHHHHHHHHHHHHH | 49.41 | - | |
87 | Ubiquitination | SLALTSFKRQQEESF HHHHHHHHHHHHHHH | 49.41 | 21906983 | |
87 | Sumoylation | SLALTSFKRQQEESF HHHHHHHHHHHHHHH | 49.41 | - | |
93 | Phosphorylation | FKRQQEESFQEQSAL HHHHHHHHHHHHHHH | 31.32 | 28555341 | |
115 | Ubiquitination | RRQELLEKITEGQAA HHHHHHHHHHHHHHH | 55.70 | 21906983 | |
123 | Ubiquitination | ITEGQAAKKQKLEQA HHHHHHHHHHHHHHH | 59.77 | 21906983 | |
123 | 2-Hydroxyisobutyrylation | ITEGQAAKKQKLEQA HHHHHHHHHHHHHHH | 59.77 | - | |
126 | Sumoylation | GQAAKKQKLEQASGA HHHHHHHHHHHHHCC | 63.97 | - | |
126 | Sumoylation | GQAAKKQKLEQASGA HHHHHHHHHHHHHCC | 63.97 | - | |
126 | Ubiquitination | GQAAKKQKLEQASGA HHHHHHHHHHHHHCC | 63.97 | 21906983 | |
131 | Phosphorylation | KQKLEQASGASSSQE HHHHHHHHCCCCCHH | 34.29 | 23090842 | |
134 | Phosphorylation | LEQASGASSSQEAGS HHHHHCCCCCHHHCC | 33.76 | 29255136 | |
135 | Phosphorylation | EQASGASSSQEAGSS HHHHCCCCCHHHCCC | 35.19 | 29255136 | |
136 | Phosphorylation | QASGASSSQEAGSSQ HHHCCCCCHHHCCCH | 29.55 | 29255136 | |
141 | Phosphorylation | SSSQEAGSSQAAKED CCCHHHCCCHHHHCC | 26.73 | 29255136 | |
142 | Phosphorylation | SSQEAGSSQAAKEDE CCHHHCCCHHHHCCC | 23.95 | 29255136 | |
150 | Phosphorylation | QAAKEDETSDGQASG HHHHCCCCCCCCCCC | 44.43 | 23090842 | |
151 | Phosphorylation | AAKEDETSDGQASGE HHHCCCCCCCCCCCC | 37.38 | 23090842 | |
156 | Phosphorylation | ETSDGQASGEQEEAG CCCCCCCCCCCCCCC | 34.67 | 23090842 | |
207 | Ubiquitination | LDWRVQSKDWPHAGR CCCCEECCCCCCCCC | 46.88 | 21906983 | |
221 | Phosphorylation | RPAHELRYSIYRDLW CCHHHHHHHHHHHHH | 16.43 | 29496907 | |
222 | Phosphorylation | PAHELRYSIYRDLWE CHHHHHHHHHHHHHH | 13.50 | 29496907 | |
224 | Phosphorylation | HELRYSIYRDLWERG HHHHHHHHHHHHHHC | 7.67 | 29496907 | |
286 | Ubiquitination | RLGTSVRKTLLLCSP CCCCCCEEEEEEECC | 41.17 | - |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of SEN34_HUMAN !! |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of SEN34_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of SEN34_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
SEN2_HUMAN | TSEN2 | physical | 15109492 | |
SEN54_HUMAN | TSEN54 | physical | 15109492 | |
ARMX3_HUMAN | ARMCX3 | physical | 22863883 | |
RBGPR_HUMAN | RAB3GAP2 | physical | 22863883 |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
612390 | Pontocerebellar hypoplasia 2C (PCH2C) | |||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Phosphorylation | |
Reference | PubMed |
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-134; SER-135 ANDSER-136, AND MASS SPECTROMETRY. |